Prof. Lichen Teng 滕立臣
Chief Physician, Professor
Department of Urology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of complex urinary and male reproductive system tumors, including kidney, ureter, bladder, prostate, penile, testicular, and adrenal tumors using laparoscopic and open techniques.
Dr. Teng is a Chief Physician, Professor, and Deputy Department Director with a medical doctorate and postdoctoral training in urology. A visiting scholar at UT Southwestern Medical Center in 2018, Dr. Teng has over ten years of clinical experience in urologic oncology. Dr. Teng has published over ten papers and leads multiple provincial research projects.
Professional roles
- Standing Committee Member and Secretary, Urology and Male Reproductive Tumor Professional Committee, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Teng Lichen). Papers usually list the name as Lichen Teng or Teng L.
Selected publications
20 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Gene Ther, 2026 (senior author): POLE2 of tumor cells promotes OPN secretion based on PCLAF to drive M2 macrophage polarization in clear cell renal cell carcinoma. PubMed 42773249
- Front Immunol, 2026 (senior author): DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway. PubMed 42253948
- Apoptosis, 2026 (senior author): Role of POLE2/GINS1-mediated AKT/mTOR pathway in RCC autophagy, proliferation, and metastasis: evidences from bioinformatic, clinical, and experimental data. PubMed 41893924
- Med Oncol, 2025 (senior author): Tβ4-17 peptide enhances the chemo-sensitivity of ovarian cancer cells to DDP by affecting NF-κB signaling pathway. PubMed 41205079
- Front Oncol, 2024 (senior author): Efficacy and safety of radical cystectomy with ileal conduit for muscle-invasive bladder cancer in the elderly: a multicenter retrospective study. PubMed 39109285
- BMC Urol, 2022 (first author): Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer. PubMed 36419012
- Asian J Urol, 2020 (first author): Total pelvic exenteration and a new model of diversion for giant primitive neuroectodermal tumor of prostate: A case report and review of the literature. PubMed 32257813
- Oncol Lett, 2018 (first author): Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro. PubMed 29725424
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion